Motofumi Hiyoshi
Osaka City University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Motofumi Hiyoshi.
Journal of Clinical Laboratory Analysis | 1998
Masaharu Yokota; Noriyuki Tatsumi; Izumi Tsuda; Takayuki Takubo; Motofumi Hiyoshi
DNA was extracted from urinary sediments and was sufficient for polymerase chain reaction (PCR) and enzymatic analysis, even if DNA from microorganisms coexisted. From urine samples, the yield of DNA ranged from trace levels to 20 μg per 10 mL urine. When urinary sediment was stored in ethanol, DNA remained stable for 2 weeks or more. Individual identification and sex determination could easily be performed using either fresh or ethanol‐fixed urine. In conclusion, urine can be used as a source for PCR‐based investigations and genetic studies. J. Clin. Lab. Anal. 12:88–91, 1998.
Acta Oto-laryngologica | 2004
Motofumi Hiyoshi; Hideo Yamane
After presenting the case of a Japanese pedigree with Pendred syndrome we discuss whether congenital hearing loss such as Pendred syndrome can be avoided.
The Journal of the Japanese Association for Infectious Diseases | 1999
Motofumi Hiyoshi; Shinichi Tagawa; Shigemi Hashimoto; Noriyuki Tatsumi
All immunocompromised hosts, such as infants, the elderly, patients with advanced cancer, and patients being treated with immunosuppressants, etc., are said to be more susceptible to cytomegalovirus (CMV) infection or CMV disease. However, we questioned the validity of this conclusion and attempted to detect CMV viremia in the plasma of subjects by using the AMPLICOR CMV test (Roche Diagnostics Systems, Branchburg, NJ), the first standardized PCR kit for CMV infection. One hundred healthy volunteers whose CMV IgG titer was < 4 and 100 healthy volunteers whose IgG titer for CMV was > or = 4 were studied. None of the subjects in either healthy group was positive for CMV viremia. Patients who were suspected of CMV infection were divided into four groups and tested: [1] 104 patients with benign disease, only one of whom was positive for CMV [2] 99 patients with hematopoietic malignancy who had not undergone bone marrow transplantation and all of whom were negative for CMV infection [3] 120 post-bone-marrow transplantation, 28 of whom were CMV positive, [4] 37 post-renal transplantation patients, 19 of whom were CMV positive. A statistically significant difference in CMV positivity was found by the non-parametric Kruskal-Wallis test (p < 0.0001) among the four disease group. CMV infection has been said to occur in all types of immunocompromised patients, however, based on our findings, we conclude that CMV infection tends to occur in post-transplantation status and does not tend to occur in patients with hematopoietic malignancy if they have not undergone transplantation.
Cell Biology International Reports | 1990
Motofumi Hiyoshi; Sasaki A; Kohzo Hashimoto; Keunsik Park; Taesung Im; Noriyuki Tatsumi; Kiyoshi Okuda
Interleukin-2 induces cytotoxic and antitumor activities of human lymphocytes. For the expression of these activities, the cytoskeletal system is probably activated. This study was do;ne to find if interleukin-2 causes cell movement. Lymphocytes were incubated with interleukin-2, and their morphology and motile activities were studied. After 72 hr of incubation, some 29% of lymphocytes were larger than before; nucleoli had formed and the microvilli were well-developed. The membrane potential of the lymphocytes increased during incubation. Motility under agar after 3 days of incubation with interleukin-2 was examined. Cells aggregated in clumps in the incubation well, and migration was not observed. When mobility was examined with Boydens method, fewer cells incubated with interleukin-2 migrated than in control preparations. Cells incubated with interleukin-2 were extracted with Triton X-100. The extract obtained had three more bands on sodium dodecyl sulfate-polyacrylamide gel electrophoresis than the controls. The band were at the positions for the molecular weights of 270,000-300,000. We concluded that interleukin-2 activated the motility of lymphocytes, but not their mobility.
Journal of Clinical Microbiology | 1997
Motofumi Hiyoshi; Shinichi Tagawa; Takayuki Takubo; Kazuo Tanaka; Takafumi Nakao; Yasuhiro Higeno; Kenichi Tamura; Masayuki Shimaoka; Atuo Fujii; Masamitsu Higashihata; Yoshinori Yasui; Taku Kim; Akira Hiraoka; Noriyuki Tatsumi
The Journal of the Japanese Association for Infectious Diseases | 1999
Motofumi Hiyoshi; Shinichi Tagawa; Shigemi Hashimoto; Chikahiko Sakamoto; Noriyuki Tatsumi
Thrombosis and Haemostasis | 1998
Motofumi Hiyoshi; Pasra Arnutti; Wichai Prayoonwiwat; Oytip Nathalang; Chamaiporn Suwanasophon; Rachapat Kokaseam; Shigemi Hashimoto; Takayuki Takubo; Shinichi Tagawa; Mitsuru Fukui; Noriyuki Tatsumi
Thrombosis and Haemostasis | 1999
Motofumi Hiyoshi; Shigemi Hashimoto; Shinichi Tagawa; Pasra Arnutti; Wichai Prayoonwiwat; Noriyuki Tatsumi
Thrombosis and Haemostasis | 1998
Pasra Arnutti; Motofumi Hiyoshi; Wichai Prayoonwiwat; Oytip Nathalang; Chamaiporn Suwanasophon; Rachapat Kokaseam; Noriyuki Tatsumi
Osaka city medical journal | 1985
Kazuhide Kojima; Sasaki A; Yasuo Yokomatsu; Motofumi Hiyoshi; Noriyuki Tatsumi; Kiyoshi Okuda; Makoto Niwa; Hajime Kitamura; Kazuyoshi Nagaki